Abstract | AIM: Cyclo-oxygenase-2 (COX2) plays a prominent role in carcinogenesis. This study addresses the effects of two nutraceutical compounds on the expression of COX2 and tumor-associated inflammation in human papillomavirus type 16 (HPV16)-transgenic mice. MATERIALS AND METHODS: Six-week-old FVB/n mice were supplemented with rutin or curcumin for 24 weeks: HPV16-/- no treatment, n=12; HPV16+/- no treatment, n=13; HPV16+/- rutin, n=12; HPV16+/- curcumin, n=13. HPV16-induced skin lesions and their inflammatory infiltrates were studied histologically. COX2 expression was assessed immunohistochemically. RESULTS:
Rutin reduced COX2 expression in the dermis (immunostaining score 7.83 versus 11.25 in untreated HPV16-transgenic mice) and epidermis (4.5 versus 10.0). Curcumin led to dermal and epidermal scores of 10.5 and 4.5. Both compounds reduced leukocytic infiltration, but neither prevented epidermal dysplasia. CONCLUSION: COX2 expression in HPV16-induced lesions may be modulated by nutraceuticals, reducing tumor-associated inflammation. However, this was not sufficient to block carcinogenesis, calling for additional studies focused on combination therapies.
|
Authors | Magda S S Moutinho, Sofia Aragão, Diogo Carmo, Fátima Casaca, Sandra Silva, Joana Ribeiro, Hugo Sousa, Isabel Pires, Felisbina Queiroga, Bruno Colaço, Rui Medeiros, Paula A Oliveira, Carlos Lopes, Margarida M S M Bastos, Rui M Gil DA Costa |
Journal | Anticancer research
(Anticancer Res)
Vol. 38
Issue 3
Pg. 1461-1466
(03 2018)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 29491072
(Publication Type: Journal Article)
|
Copyright | Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Rutin
- Cyclooxygenase 2
- Curcumin
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(pharmacology)
- Curcumin
(pharmacology)
- Cyclooxygenase 2
(metabolism)
- Disease Progression
- Down-Regulation
(drug effects)
- Female
- Human papillomavirus 16
(genetics, physiology)
- Humans
- Inflammation
(complications, metabolism, prevention & control)
- Leukocytes
(drug effects, pathology)
- Mice, Transgenic
- Papillomavirus Infections
(complications, virology)
- Rutin
(pharmacology)
- Skin
(drug effects, metabolism, pathology)
- Skin Neoplasms
(complications, metabolism, prevention & control)
|